Skip to main content
PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · IEX Real-Time Price · USD
51.83
-0.45 (-0.86%)
At close: Apr 26, 2024, 4:00 PM
51.29
-0.54 (-1.04%)
After-hours: Apr 26, 2024, 6:55 PM EDT

PROCEPT BioRobotics Revenue

In the year 2023, PROCEPT BioRobotics had annual revenue of $136.19M with 81.55% growth. Revenue in the quarter ending December 31, 2023 was $43.58M with 83.29% year-over-year growth.

Revenue (ttm)
$136.19M
Revenue Growth
+81.55%
P/S Ratio
19.40
Revenue / Employee
$217,558
Employees
626
Market Cap
2.64B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023136.19M61.18M81.55%
Dec 31, 202275.01M40.54M117.60%
Dec 31, 202134.47M26.76M346.72%
Dec 31, 20207.72M1.55M25.09%
Dec 31, 20196.17M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
QuidelOrtho 3.00B
GoodRx Holdings 750.27M
ACADIA Pharmaceuticals 726.44M
Certara 354.34M
MorphoSys AG 264.75M
Arrowhead Pharmaceuticals 181.74M
Arcellx 110.32M
Merus 43.95M
Revenue Rankings

PRCT News

More News